Reichel D, Kölmel H W
Neurologische Klinik und Poliklinik am Klinikum Erfurt.
Z Arztl Fortbild (Jena). 1995 May;89(2):151-8.
The rational drug-treatment of multiple sclerosis on an immunological basis requires an acquaintance with the different forms of the disease course along with an understanding of the underlying pathomechanisms as well as a thorough knowledge of the chances and limitations of such a therapy. Besides some well established treatment regimens other approaches are presented which are currently evaluated in clinical trials and their effects and side effects are discussed.